These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 15776124

  • 1. Cyclooxygenase-2 inhibitors and cardiovascular risk.
    Smith ER.
    Can J Cardiol; 2005 Mar; 21(3):307-8. PubMed ID: 15776124
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. COX-2 inhibitors--a lesson in unexpected problems.
    Drazen JM.
    N Engl J Med; 2005 Mar 17; 352(11):1131-2. PubMed ID: 15713947
    [No Abstract] [Full Text] [Related]

  • 6. The lessons of Vioxx.
    Frazier KC.
    N Engl J Med; 2005 Sep 29; 353(13):1420-1; author reply 1420-1. PubMed ID: 16192497
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Trying times for painkiller choices. Vioxx, Bextra, and Celebrex can increase the risk for heart attack and other cardiovascular problems. So can the old standbys, like ibuprofen and acetaminophen.
    Harv Heart Lett; 2006 Oct 29; 17(2):1-3. PubMed ID: 17153752
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
    Ray WA, MacDonald TM, Solomon DH, Graham DJ, Avorn J.
    Pharmacoepidemiol Drug Saf; 2003 Oct 29; 12(1):67-70. PubMed ID: 12616850
    [No Abstract] [Full Text] [Related]

  • 12. COX-2 inhibitors and the heart: putting risk in perspective.
    Bobadilla RV, Barnett EM, Randels CL.
    Adv Nurse Pract; 2005 Nov 29; 13(11):48-50. PubMed ID: 16295003
    [No Abstract] [Full Text] [Related]

  • 13. [COX-2 inhibitors--one step forward and two steps back].
    Evensen S, Spigset O, Slørdal L.
    Tidsskr Nor Laegeforen; 2005 Apr 07; 125(7):875-8. PubMed ID: 15815733
    [Abstract] [Full Text] [Related]

  • 14. Coxibs and cardiovascular disease.
    Fitzgerald GA.
    N Engl J Med; 2004 Oct 21; 351(17):1709-11. PubMed ID: 15470192
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cyclooxygenase inhibition and adverse remodeling during healing after myocardial infarction.
    Jugdutt BI.
    Circulation; 2007 Jan 23; 115(3):288-91. PubMed ID: 17242292
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The Vioxx debacle revisited.
    Mohapatra PR, Janmeja AK.
    Am J Med; 2005 Sep 23; 118(9):1058. PubMed ID: 16164909
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.